InvestorsHub Logo
Followers 23
Posts 1757
Boards Moderated 0
Alias Born 06/07/2016

Re: Hungry_Ghost post# 392806

Sunday, 09/04/2022 2:35:18 PM

Sunday, September 04, 2022 2:35:18 PM

Post# of 403017
There was lots of speculation about the reason why IPIX bought a substantial piece of Squalus Medical per the excerpt that follows from the PR announcement. Stay tuned for a potential big reveal. Investors won't be selling until all is made known. Good luck to INVESTORS in IPIX.

WAKEFIELD, MA / ACCESSWIRE / June 15, 2022 / Innovation Pharmaceuticals (OTCQB:IPIX) ("the Company"), a clinical stage biopharmaceutical company, today announced that the Company has acquired a minority stake in Israel-based Squalus Medical, the inventor and developer of the Sting Ray Laser System (the "StingRay System"), a novel laser-based thermal ablation technology designed for treatment of previously inoperable cases of epilepsy and for improvement of outcomes and enablement of new treatment options for oncology procedures, including those treating brain, prostate, liver, breast and lung cancers.

The StingRay System combines new fiber optic technology with an advanced laser console and computerized intelligent control that allows an excellent match between the structure of tumors and epileptic focal points and the energy delivery, while protecting vital functional areas against thermal damage. The console integrates advanced imaging modalities, and guides the physician, making sure the treatment is adjusted to the specific patient needs with real time energy control.

The StingRay System is supported by Squalus' proprietary technologies that deliver remarkable properties for controlling laser energy.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News